All In Biotech

Drug Trial Radar · NCT05636228

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Patients With Acute Infectious Keratoconjunctivitis

Last checked: Nov 19, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

93

Actual

Start

Jun 9, 2023

Primary completion

Aug 22, 2024

Study completion Aug 22, 2024

Sponsor

Lead sponsor
Invirsa, Inc.Industry
Sponsor type
Industry
Collaborators
Biomedical Advanced Research and Development Authority
First posted
Dec 5, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 2, randomized study to assess topically administered eyedrops of INV-102 compared to vehicle during 1-week dosing in participants with Acute Infectious Keratoconjunctivitis (AIK). Participants will return for a follow up visit 1 week after end of treatment.

Conditions

  • Acute Infectious Keratoconjunctivitis

Interventions

  • INV-102Drug

    INV-102 Ophthalmic Solution

  • VehicleDrug

    Vehicle Ophthalmic Solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To Evaluate the Change in Combined Clinical ScoreTime frame: Through End of Treatment (Day 8)

Locations

12 sites in 2 countries. Site status is shown where the registry gives one.

  • Global Research Management

    Glendale, California

  • Foothill Eye Institute

    Pasadena, California

  • Shettle Eye Research

    Largo, Florida

  • D & H National Research Centers, INC

    Miami, Florida

  • My Community Research Center, Inc.

    Miami, Florida

  • Quantum Clinical Trials

    Miami Beach, Florida

  • Kannarr Eye Center

    Pittsburg, Kansas

  • Oculos Clinical Research

    Garner, North Carolina

  • Athens Eye Care

    Athens, Ohio

  • Revolution Research/ Lake Travis Eye and Laser Center

    Lakeway, Texas

  • King Chulalongkorn Memorial Hospital

    Bangkok, Thailand

  • Mahidol university

    Bangkok, Thailand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.